Disease | hepatitis b |
Symptom | |infection |
Sentences | 596 |
PubMedID- 22166776 | The most frequent infectious and parasitic diseases are hepatitis c virus (hcv) infection with a prevalence of 9.0%, hepatitis b virus (hbv) infection (2.2%), and human immunodeficiency virus (hiv) infection (1.4%). |
PubMedID- 23304062 | Chronic infection with hepatitis b virus (hbv) affects more than 350 million people worldwide and continues to be an important cause of morbidity and mortality 1. |
PubMedID- 24626096 | The screening of smart and esprit participants for co-infection with hepatitis b (hbv) or hepatitis c (hcv) has been reported elsewhere . |
PubMedID- 20396673 | infection with hepatitis b virus (hbv) persists as a worldwide public health problem, with vertical transmission of hbv being responsible for approximately one third of all new cases of hepatitis b. childhood hepatitis b immunisation has significantly reduced the incidence and prevalence of hbv infection 1, and currently more than 160 countries use hepatitis b vaccine in their national immunisation programmes. |
PubMedID- 24179516 | The most common risk factors for hcc are chronic infection with hepatitis b virus or hepatitis c virus. |
PubMedID- 23436024 | Chronic infection with hepatitis b (hbv) or c (hcv) virus, which currently affect approximately 7 % of the world population, is encountered with the same frequency among patients with arthritis starting biological or non-biological disease-modifying anti-rheumatic drugs (dmards). |
PubMedID- 26011625 | Various risk factors for hepatocellular carcinoma (hcc) exist, including infection with hepatitis b virus (hbv) and hepatitis c virus, alcoholic and non-alcoholic fatty liver disease, and several hereditary metabolic diseases.1 however, chronic liver injury, typically cirrhosis, is the most important and common setting for the development of hcc. |
PubMedID- 23833647 | Multiple pathogenic factors, including infection with the hepatitis b and c viruses (hbv and hcv) and the subsequent multistage pathogenesis of hcc have been studied extensively. |
PubMedID- 25827821 | infection with chronic hepatitis b or c virus is currently the dominant risk factor worldwide. |
PubMedID- 23913498 | Pattern and risk factors for partner infection with hepatitis b virus in a prevention of mother-to-child transmission programme. |
PubMedID- 21573126 | While several causal agents for hcc have been identified, including infection with hepatitis b and c viruses (hbv and hcv), there is no effective treatment for this cancer type, in part because the molecular and cellular mechanisms of hcc development are still poorly understood , , . |
PubMedID- 22911677 | Chronic infection with hepatitis b virus (hbv) is present in an estimated 360 million individuals worldwide, and is an important cause of liver cirrhosis and liver cancer . |
PubMedID- 21541950 | Prevalence and clinical significance of hepatitis d virus co-infection in patients with chronic hepatitis b in korea. |
PubMedID- 23665172 | Co-infection with hepatitis b does not alter treatment response in chronic hepatitis c. |
PubMedID- 25270965 | Above well-known risk factors for hcc development ranging from various toxins to diseases such as diabetes mellitus, chronic infection with hepatitis b virus and hepatitis c virus (hcv) poses the most serious threat, constituting the cause in more than 80 % of cases. |
PubMedID- 22068163 | Objective: to examine recent trends of acute infection with hepatitis b virus (hbv) in japan by nationwide surveillance and phylogenetic analyses. |
PubMedID- 22205924 | These geographical variations are in part explained by variations in the prevalence of chronic infection with hepatitis b virus (hbv) and/or hepatitis c virus (hcv). |
PubMedID- 24172202 | It has been well noted that infection with hepatitis b and c virus (hbv and hcv) is the main etiological factor for the development of hcc (1,4-8). |
PubMedID- 23963804 | In endemic areas of sub-saharan africa and asia, plc largely arises from chronic infection with hepatitis b virus (hbv) and ingestion of aflatoxins. |
PubMedID- 21434717 | When prophylactic measures have failed and graft infection has occurred, treatment of recurrent hepatitis b may be based on the resistance profile of the virus and previous antiviral exposure. |
PubMedID- 20085587 | In addition, a possible association between chronic infection with hepatitis b and c viruses and cholangiocarcinoma was also noted. |
PubMedID- 23527168 | Background: sub-saharan africa carries a high burden of co-infection with hiv-1 and hepatitis b virus (hbv). |
PubMedID- PMC3019406 | Approximately one-third of the world’s population has serological evidence of infection with hepatitis b virus (hbv). |
PubMedID- 21771458 | Methods: three hundred and thirty seven (337) potential blood donors, comprising 229(67.95%) males and 108(32.05%) females were screened for co-infection with hepatitis b virus (hbv) and plasmodia between the months of july and december, 2009 using standard laboratory methods. |
PubMedID- 22783343 | showed no significant difference in frequencies of genotypes and alleles of il-10 gene promoter region at position -1082 g/a, -819 t/c, -592 a/c among normal controls, individuals spontaneously recovering from hbv infection, and patients with chronic hepatitis b. however, they reported that frequencies of t/t genotype at position -819 and a/a genotype at position -592 in chronic hepatitis b were significantly higher than that in asymptomatic hbv carriers. |
PubMedID- 23516510 | Persistent infection with hepatitis b virus (hbv) and/or hepatitis c virus (hcv) is the major cause of hepatocellular carcinoma (hcc) worldwide. |
PubMedID- 22419004 | Most patients with hcc have an underlying liver disease caused by either chronic viral infection due to hepatitis b or hepatitis c virus or non-viral etiologic risk factors such as alcohol, fatty liver disease, dietary aflatoxin exposure, smoking and diabetes mellitus. |
PubMedID- 23401707 | infection with hepatitis b virus (hbv) is a critical health problem worldwide. |
PubMedID- 22682366 | Because of high infection rates with hepatitis b virus (hbv), 55% of world’s hcc cases occur in the country 4. |
PubMedID- 24753925 | If the woman is at increased risk of infection with hepatitis b and is not yet vaccinated it is recommended to administer hep b vaccine. |
PubMedID- 23910648 | Chronic infection with the hepatitis b virus (hbv) is a frequent cause of cirrhosis and liver cancer. |
PubMedID- 24379608 | Chronic infection with hepatitis b virus (hbv) and hepatitis c virus accounts for approximately 75%-80% of hcc cases worldwide. |
PubMedID- 22190911 | Innate and adaptive immune systems have important role in the pathogenesis of acute and chronic infection with hepatitis b virus (hbv). |
PubMedID- 26490438 | The primary risk factor for hcc is liver cirrhosis secondary to persistent infection with hepatitis b virus (hbv) or hepatitis c virus (hcv). |
PubMedID- 23320393 | It has been well documented that infection with hepatitis b and c virus (hbv and hcv) is the major etiological factor for the development of hcc . |
PubMedID- 23802710 | A method for estimating the residual risk of transfusion-transmitted hbv infection associated with occult hepatitis b virus infection in a donor population without universal anti-hbc screening. |
PubMedID- 25893086 | Reactivation of infection with hepatitis b virus (hbv) and/or hepatitis c virus (hcv) is defined as increased viral replication in patients with previously low-grade chronic infection. |
PubMedID- 24618505 | Goals: we evaluated whether prior infection with the hepatitis b virus (hbv) influences the development of pancreatic cancer or hepatocellular carcinoma (hcc). |
PubMedID- 23509784 | Chronic infection with hepatitis b virus (hbv) is associated with the majority of cases of liver cirrhosis (lc) in china. |
PubMedID- 24779356 | Chronic infection with hepatitis b virus (hbv) results in an estimated 786 000 deaths annually worldwide 1. infected individuals may remain asymptomatic for long periods but are at risk of progressive liver disease, and can transmit the virus to other susceptible individuals. |
PubMedID- 24691105 | This condition is the end result of long-term (chronic) liver damage caused by, for example, alcohol abuse or infection with hepatitis b virus (hbv). |
PubMedID- 22276183 | Chronic infection with hepatitis b virus (hbv) is a major worldwide issue in public health and is one of the best known high-risk factors for cirrhosis and hepatocellular carcinoma (hcc) . |
PubMedID- 26020957 | The onset and progression of hcc is related to risk factors such as chronic infection with hepatitis b and c viruses and exposure to hepatocarcinogen aflatoxin b1 1. |
PubMedID- 25603021 | The etiology of hcc includes chronic infection with hepatitis b and c viruses, cirrhosis, and exposure to dietary and environmental hepatocarcinogens. |
PubMedID- 23674855 | Exclusion criteria included: patients on ifn-alpha therapy, infection with hepatitis b or hepatitis i virus, hepatocellular carcinoma, other malignancies, major severe illness, or treatment non-compliance. |
PubMedID- 24682088 | Chronic infection with hepatitis b virus (hbv) currently affects about 400 million people worldwide, and leads to complications of cirrhosis, hepatic decompensation and hepatocellular carcinoma (hcc). |
PubMedID- 21951512 | Hepatocellular carcinoma (hcc) is mainly caused by a persistent infection due to the hepatitis b or hepatitis c virus. |
PubMedID- 21746810 | Unlike liver cirrhosis, which, in many developing countries frequently follows chronic infection with hepatitis b or c virus, pulmonary fibrosis, and particularly idiopathic pulmonary fibrosis (ipf)—the most frequent and devastating form of the disease—typically follows noninfectious (i.e., physicochemical) tissue injury (rogliani et al., 2008). |
PubMedID- 26218239 | There has been a recent revival of political and clinical interest in the problem of infection with hepatitis b virus (hbv) in sub-saharan african populations in whom human immunodeficiency virus (hiv) is also frequently endemic . |
PubMedID- 25099333 | Studies on the prevalence of infection with hepatitis b virus (hbv) among children are scarce in latin american countries, especially in mexico. |